AspirinAnti-Inflammatory Agents, Non-SteroidalIbuprofenCyclooxygenase InhibitorsCyclooxygenase 2 InhibitorsNaproxenDiclofenacPlatelet Aggregation InhibitorsSulindacFlurbiprofenProstaglandin-Endoperoxide SynthasesIndomethacinPiroxicamCyclooxygenase 1Cyclooxygenase 2AcetaminophenKetoprofenSalicylatesThromboxane B2EtodolacPyrazolesSulfonamidesTolmetinSodium SalicylateDrug Therapy, CombinationTiclopidineThiazinesPlatelet AggregationStomach UlcerDose-Response Relationship, DrugDouble-Blind MethodGastrointestinal HemorrhageKetorolacTime FactorsGastrointestinal DiseasesDinoprostoneAnalgesics, Non-NarcoticProstaglandinsPhenylbutazoneDrug InteractionsAnti-Inflammatory AgentsNitrobenzenesTreatment OutcomeGrowth Differentiation Factor 15SulfonesRisk FactorsAdministration, OralPlatelet Function TestsDrug Administration ScheduleDrug HypersensitivityLactonesFenoprofenIsoenzymesGastric MucosaAnalgesicsProspective StudiesStereoisomerismAsthma, Aspirin-InducedAnticarcinogenic AgentsChemopreventionBlood PlateletsWarfarinAnticoagulantsPeptic Ulcer HemorrhageThromboxanesDiflunisalTropaeolaceaeOxyphenbutazoneCase-Control StudiesProstaglandin AntagonistsPeptic UlcerNonsteroidal Anti-AndrogensHemorrhageMolecular StructureFibrinolytic AgentsClonixinLipoxinsButanonesFollow-Up StudiesTablets, Enteric-CoatedRadiation DosageLethal Dose 50Colorectal NeoplasmsColonic NeoplasmsRats, WistarSalicylic AcidMagnetic Resonance SpectroscopyBleeding TimePhenylpropionatesArthritisModels, MolecularAntibodies, MonoclonalMembrane ProteinsAromatase InhibitorsAntineoplastic AgentsPainAnti-Ulcer AgentsPlatelet ActivationRats, Sprague-DawleyArachidonic Acid